Ljubomir Isakovic - Concepedia

Author

Ljubomir Isakovic

Pyrogenesis (Canada)

Also Known As

L. Isakovic, Ljubomir Isakovic

Publications

332

Citations

H-Index

Concepts

All Affiliations

Pyrogenesis (Canada)McGill University

About

Ljubomir Isakovic is an author at Pyrogenesis (Canada) specializing in natural sciences, drug discovery, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	6	6	224
2	Medicine	5	5	175
3	Biochemistry	5	5	199
4	Engineering	1	1	25
5	Biomolecular Engineering	1	1	25

Ljubomir Isakovic

Publications

322

Citations

H-Index

Page 1

	Year	Citations
Application of Lewis Acid Catalyzed Tropone [6+4] Cycloadditions to the Synthesis of the Core of CP-225,917 Ljubomir Isakovic, James A. Ashenhurst, James L. Gleason Organic Letters	2001	71
Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors Ljubomir Isakovic, Oscar M. Saavedra, David B. Llewellyn, Bioorganic & Medicinal Chemistry Letters Dna Methyltransferase InhibitorsMedicinal ChemistryBiochemistryNatural SciencesOligonucleotide	2009	51
N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors Michael R. Mannion, Stéphane Raeppel, Stephen Claridge, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetNovel SeriesBiochemistryMedicine	2009	50
SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes Oscar M. Saavedra, Ljubomir Isakovic, David B. Llewellyn, Bioorganic & Medicinal Chemistry Letters BiochemistryNatural SciencesEpigenetic ChangeDna MethylationEpigenomics	2009	49
N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors Stéphane Raeppel, Stephen Claridge, Oscar Saavedra, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetNovel SeriesBiochemistryMedicine	2009	34
N3-Arylmalonamides: A new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases Oscar Saavedra, Stephen Claridge, Lijie Zhan, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryVegfr2 Tyrosine KinasesMedicineRational Drug DesignPharmacological Agent	2009	27
Application of a [6+4] cycloaddition strategy toward the total synthesis of CP-225,917 James A. Ashenhurst, Ljubomir Isakovic, James L. Gleason Tetrahedron EngineeringHeterocyclicNatural SciencesDiversity-oriented SynthesisTotal Synthesis	2009	25
Identification of a novel series of potent RON receptor tyrosine kinase inhibitors Stéphane Raeppel, Frédéric Gaudette, Michael R. Mannion, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetNovel SeriesBiochemistryMedicine	2010	15

Page 1